1 / 15

HSV Encephalitis

HSV Encephalitis. Jack Kuritzky, PGY-2 UNC Internal Medicine August 31, 2009. HSV Encephalitis: General. Encephalitis: 20,000 cases/year HSV accounts for 10-20% HSV-1 causes encephalitis in adults HSV-1 or HSV-2 in neonates HSV-1 and 2 associated w/Mollaret’s meningitis

duke
Download Presentation

HSV Encephalitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. HSV Encephalitis Jack Kuritzky, PGY-2 UNC Internal Medicine August 31, 2009

  2. HSV Encephalitis: General • Encephalitis: 20,000 cases/year • HSV accounts for 10-20% • HSV-1 causes encephalitis in adults • HSV-1 or HSV-2 in neonates • HSV-1 and 2 associated w/Mollaret’s meningitis • Benign recurrent lymphocytic meningitis • Preferentially affects temporal lobe • Can rarely cause recurrent brainstem encephalitis • HSV-2 tends to cause global encephalitis • 1/3 cases <20yrs and 1/2 cases >50 yrs

  3. HSV Encephalitis: Pathogenesis • Infiltrates CNS via 3 routes • 1. Trigeminal nerve or olfactory tract • Typically after primary infection • <18yrs old • 2. CNS invasion after recurrent infection • Viral reactivation w/subsequent spread • 3. CNS infection w/o primary or recurrent HSV-1 • Latent HSV in situ within CNS • Invades and replicates in neurons and glia • Causes necrotizing encephalitis • Widespread hemorrhagic necrosis throughout parenchyma

  4. HSV Encephalitis: Pathogenesis • Necrosis of temporal lobe

  5. HSV Encephalitis: Pathogenesis • Necrosis of temporal lobe • Immune mediated • Not more common in immunosuppressed • Small studies suggest HSV viral load does not correlate with degree of temporal lobe damage

  6. HSV Encephalitis: Presentation • Fever • Altered mental status • Altered level of consciousness • Focal cranial nerve deficits • Hemiparesis • Dysphasia/aphasia • Ataxia • Focal seizures

  7. HSV Encephalitis: Presentation • Fever • Altered mental status • Altered level of consciousness • Focal cranial nerve deficits • Hemiparesis • Dysphasia/aphasia • Ataxia • Focal seizures

  8. HSV Encephalitis: Presentation • More on AMS – consequences of temporal lobe damage • Hypomania - elevated mood, excessive animation, decreased need for sleep, inflated self-esteem, and hypersexuality • Kluver-Bucy syndrome (KBS) • Initially seen in Rhesus monkeys • Loss of normal anger and fear responses • Increased sexual activity • Amnesia

  9. HSV Encephalitis: Diagnosis • CSF • Lymphocytic pleocytosis • Erythrocytosis (84% of patients) • Elevated protein • Low glucose uncommon • CSF PCR now diagnostic test of choice • Quickest, sensitive, and specific • HSV culture out of favor • Brain biopsies previously performed

  10. HSV Encephalitis: Diagnosis • Imaging • Temporal lobe injury

  11. HSV Encephalitis: Diagnosis • Imaging – Temporal lobe injury • Usually unilateral • May have mass effect • MRI much more sensitive/specific • EEG – focal findings in >80% cases • High amplitude slow waves (delta and theta slowing) • Continuous periodic lateralized epileptiform discharges in the affected region

  12. HSV Encephalitis: Treatment • EARLY TREATMENT IMPERATIVE! • Before loss of consciousness • Within 24 hours of the onset of symptoms • Glasgow Coma Scale score of 9 to 15 • Acyclovir 10 mg/kg IV Q 8h (infuse slowly to prevent crystalluria/renal failure) • Mortality 19-28% vs. 50-58% w/vidarabine • 6 month functional status significantly better w/acyclovir • Treat 14-21 days • Future treatment  steroids? (non-randomized, retrospective study)

  13. HSV Encephalitis: Prognosis • Untreated, mortality 70% • Survivors with severe neurologic damage • With treatment—mortality ~20%! • Severe disability in 20% • Simplified Acute Physiology Score II >/=27 • Delay >2 days b/w admission and acyclovir • GCS <6 • Age>30 • 62% of survivors have neurologic sequelae

  14. REFERENCES Kimberline, DW. Management of HSV Encephalitis in Adults and Neonates: Diagnosis, Prognosis, and treatment. Herpes. (14)1. 2007. Klein, R. “Clinical manifestations and diagnosis of herpes simplex virus type 1 infection”. UpToDate, version 17.2. Jan 2009. Klein, R. “Herpes Simplex Type 1 Encephalitis”. UpToDate, version 17.2. Feb 2009. Shandera, WX and H Koo. “Infectious Diseases: Viral & Rickettsial”. 2007 Current Medical Diagnosis & Treatment. 46th ed. The McGraw Hill Companies: USA. 2007.

  15. THE END

More Related